In certain scenarios, a patient may be not able to change an antiretroviral regimen which has significant prospective interactions with the encouraged HCV treatment regimens. In this sort of circumstances, daclatasvir combined with sofosbuvir is the popular treatment. [138] Ribavirin may very well be added on, dependant upon the HCV genotype and pr